| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 02/21/2012 | US8119368 Process for the culturing of cells |
| 02/21/2012 | US8119366 Antennapedia-dominant negative mastermind-like construct |
| 02/21/2012 | US8119364 Methods for generating analogs of coenzyme A |
| 02/21/2012 | US8119362 Method of screening for compounds that can be used for the treatment of respiratory conditions |
| 02/21/2012 | US8119361 Methods of cleaving DNA with rationally-designed meganucleases |
| 02/21/2012 | US8119359 Methods of indentifying sweet taste modulators |
| 02/21/2012 | US8119354 Cell-free assay product and method of use thereof for measuring activity of frizzled receptors |
| 02/21/2012 | US8119146 Expressing hepatitis B virus surface antigen for vaccine preparation |
| 02/21/2012 | US8119145 Methods for producing norovirus VLPS |
| 02/21/2012 | US8119131 IL-17 antagonistic antibodies |
| 02/21/2012 | US8119130 Targeted binding agents directed to KDR and uses thereof—035 |
| 02/21/2012 | CA2615833C Growth-stimulating polypeptides for use in fish and crustaceans |
| 02/21/2012 | CA2506247C Novel aldolase, and method for producing optically active ihog and monatin |
| 02/21/2012 | CA2487116C Fermentation process using specific oxygen uptake rates as a process control |
| 02/21/2012 | CA2418962C Anti-dual integrin antibodies, compositions, methods and uses |
| 02/21/2012 | CA2412460C Human monoclonal antibody against hepatitis c virus e2 glycoprotein |
| 02/21/2012 | CA2407680C Dendritic cell co-stimulator molecules |
| 02/21/2012 | CA2353698C Human hybrid host cell for mammalian gene expression |
| 02/21/2012 | CA2322055C Novel mechanically sensitive mammal potassium channel family activated by polyunsaturated fatty acids and their use particularly for screening medicines |
| 02/21/2012 | CA2296841C Tropoelastin derivatives |
| 02/21/2012 | CA2263835C Stimulus-inducible i (kappa)b kinase [ikk] signalsome |
| 02/21/2012 | CA2230759C Chimeric animal and method for producing the same |
| 02/16/2012 | WO2012021876A2 Peptidomimetic macrocycles |
| 02/16/2012 | WO2012020622A1 Fragment of humanized anti-egfr antibody substituted-lysine variable fragment and use thereof |
| 02/16/2012 | WO2012019291A1 Preparation and purification of subunit vaccine for neisseria meningitidis (nm) group b isolates |
| 02/16/2012 | WO2011091350A9 Methods & compositions for improving protein production |
| 02/16/2012 | WO2005110456A8 T-cell death-inducing epitopes |
| 02/16/2012 | US20120042416 Antibody fusion-mediated plant resistance against Oomycota |
| 02/16/2012 | US20120042400 Rtd receptor |
| 02/16/2012 | US20120041177 Method of producing polymers of spider silk proteins |
| 02/16/2012 | US20120041176 Ucp4 |
| 02/16/2012 | US20120041171 Process for the production of a recombinant polypeptide of interest |
| 02/16/2012 | US20120040917 Splice Switching Oligomers for TNF Superfamily Receptors and Their Use in Treatment of Disease |
| 02/16/2012 | US20120040416 Novel aldolase and production process of substituted alpha-keto acids |
| 02/16/2012 | US20120040402 Plasmid system for multigene expression |
| 02/16/2012 | US20120040401 Method For Producing Proteins |
| 02/16/2012 | US20120040400 Novel Permanent Human Cell Line |
| 02/16/2012 | US20120040399 Method for the production of recombinant polyomaviral vector particles |
| 02/16/2012 | US20120040398 Engineered cleavage half-domains |
| 02/16/2012 | US20120040397 Photo-Crosslinked Nucleic Acid Hydrogels |
| 02/16/2012 | US20120040385 Coagulogen raw material, process for producing the same, and method and apparatus for measuring physiologically active substance of biological origin using the same |
| 02/16/2012 | US20120039936 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva) |
| 02/16/2012 | US20120039911 Cd93 or use of soluble fragment thereof |
| 02/16/2012 | US20120039904 Anti system asc amino acid transporter 2 (asct2) antibody |
| 02/16/2012 | US20120039898 Human binding molecules capable of neutralizing influenza virus h3n2 and uses thereof |
| 02/16/2012 | US20120039890 Methods of treatment using antibodies to neutrokine-alpha |
| 02/16/2012 | US20120039880 FRAGMENTATION RESISTANT IgG1 Fc-CONJUGATES |
| 02/16/2012 | US20120039874 Human monoclonal antibody against a costimulatory signal transduction molecule ailim and pharmaceutical use thereof |
| 02/16/2012 | US20120039870 Binding molecules with multiple binding sites, compositions comprising the same and uses thereof |
| 02/16/2012 | US20120039869 Methods of using molecular conjugates comprising monoclonal antibodies to dendritic cells |
| 02/16/2012 | US20120039855 Fibrin based scaffold, preparation and use thereof |
| 02/16/2012 | US20120039807 Anti-Tenascin-C A2 Antibodies and Methods of Use |
| 02/15/2012 | EP2418281A2 Methods and compositions for delivering polynucleotides |
| 02/15/2012 | EP2418278A2 Human monoclonal antibodies to programmed death 1(PD-1) and methods for treating cancer using anti-PD-1 antibodies alone or in combination with other immunotherapeutics |
| 02/15/2012 | EP2418274A2 Multimeric Oxidoreductases |
| 02/15/2012 | EP2418222A1 Therapeutic agent for diseases in which neoplastic proliferation of plasma cells occurs |
| 02/15/2012 | EP2418212A1 Isolation of five novel genes coding for new fc receptors-type melanoma involved in the pathogenesis of lymphoma/melanoma |
| 02/15/2012 | EP2416807A1 Novel strategies for improved cancer vaccines |
| 02/15/2012 | EP1951891B1 Cancer antigen mage-a9 and uses thereof |
| 02/15/2012 | EP1636268B1 Humanized antibodies that recognize beta amyloid peptide |
| 02/15/2012 | EP1532446B1 G-protein coupled receptor ligands and methods |
| 02/15/2012 | EP1309705B1 Multivalent target binding protein |
| 02/15/2012 | CN102356317A A method for measuring beta-glucan, and beta-glucan-binding protein for use in the method |
| 02/15/2012 | CN102352399A Extraction method of protolysate |
| 02/15/2012 | CN102352398A Casein active single peptide as well as preparation method and application thereof |
| 02/15/2012 | CN102352397A Production of recombinant insulin-like growth factor-I (IGF-I) and insulin-like growth factor binding protein-3 (IGFBP-3) in transgenic monocots |
| 02/15/2012 | CN102352337A Recombinant bacteria expressed by escherichia coli genome N-acetylase by control of heterogenous promoter, and use thereof |
| 02/15/2012 | CN102352227A Lipopeptide biosurfactant, preparation method thereof, and application thereof |
| 02/15/2012 | CN101633699B 一种含抗体模拟物的新型抗生素及其制备方法与应用 New antibiotics and its preparation method and application containing antibody mimetics |
| 02/14/2012 | US8115063 Bacillus thuringiensis gene with coleopteran activity |
| 02/14/2012 | US8114977 Proteins derived from white spot syndrome virus and uses thereof |
| 02/14/2012 | US8114976 Cryptosporidium hominis genes and gene products for chemotherapeutic, immunoprophylactic and diagnostic applications |
| 02/14/2012 | US8114967 Constructs and libraries comprising antibody surrogate light chain sequences |
| 02/14/2012 | US8114966 Peptide-based passive immunization therapy for treatment of atherosclerosis |
| 02/14/2012 | US8114965 Compositions of PSMA antibodies |
| 02/14/2012 | US8114964 Anti-MCP-1 antibodies, compositions, methods and uses |
| 02/14/2012 | US8114960 Heterologous expression of Neisserial proteins |
| 02/14/2012 | US8114849 Retinal dystrophy-associated protein and uses thereof |
| 02/14/2012 | US8114655 EGVII endoglucanase and nucleic acids encoding the same |
| 02/14/2012 | US8114654 Site-specific incorporation of redox active amino acids into proteins |
| 02/14/2012 | US8114653 Thermostable Y-family polymerases and chimeras |
| 02/14/2012 | US8114652 Genetically programmed expression of selectively sulfated proteins in eubacteria |
| 02/14/2012 | US8114651 Method for producing 4-hydroxy-L-isoleucine |
| 02/14/2012 | US8114650 Nucleic acid and its use effecting ciliate tetrahymena bifunctional dihydrofolate reductase-thymidylate synthase deficiency |
| 02/14/2012 | US8114648 immunizing a subject with a sufficient amount of a translated polypeptide to produce antibody; containing a phenylalanine or tyrosine derivative analoges |
| 02/14/2012 | US8114643 Producing 3-hydroxypropionic acid from transgenic organisms such as plants or bacteria that express vicinal diol dehydratase, aldehyde dehydrogenase, acyl-CoA transferase, acyl-CoA synthetase, polyhydroxyalkanoate synthase, glycerol-3-phosphate dehydrogenase and/or glycerol-3-phosphatase |
| 02/14/2012 | US8114641 Made from biosynthesis; can be further converted to bis(2-methyl)butyl ether or 3,3,5-trimethylheptane; fuel addtive, biofuel-fossil fuel blends, or biofuels |
| 02/14/2012 | US8114635 Methods for obtaining microbial trypsin mutants having chymotrypsin activity |
| 02/14/2012 | US8114634 Methods, systems and reagents for improved immunodetection |
| 02/14/2012 | US8114633 Methods for differentiating plasma-derived protein from recombinant protein in a sample |
| 02/14/2012 | US8114632 Method of producing biologically active polypeptide having insulinotropic activity |
| 02/14/2012 | US8114630 Modified interferon beta polypeptides and their uses |
| 02/14/2012 | US8114629 Site specific incorporation of keto amino acids into proteins |
| 02/14/2012 | US8114628 Expanding the eukaryotic genetic code |
| 02/14/2012 | US8114626 Yeast strain and method for using the same to produce nicotinamide riboside |
| 02/14/2012 | US8114417 Recombinant protective protein from Streptococcus pneumoniae |
| 02/14/2012 | US8114415 Method for producing temperature sensitive influenza A viruses |
| 02/14/2012 | US8114401 Chlamydia trachomatis antigens |
| 02/14/2012 | US8113950 Competition entry with limited return messaging |
| 02/14/2012 | CA2387870C Stabilized proteins |